ArticleThe American journal of case reports2026
Rare Systemic Vasculitides: Polyarteritis Nodosa and Takayasu Arteritis.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Polyarteritis nodosa (PAN) and Takayasu arteritis (TA) are systemic medium- and large-vessel vasculitides associated with significant morbidity when diagnosis is delayed. Although described in the literature, reports directly demonstrating the impact of diagnostic timing on vascular outcomes remain limited. This report presents 2 rare and contrasting cases highlighting the importance of early recognition with timely vascular and immunosuppressive interventions, which can prevent irreversible ischemic complications, whereas delayed diagnosis can result in permanent structural damage, reinforcing the need for accurate differentiation between PAN and TA. CASE REPORT Case 1 was a young woman with refractory hypertension and significant vascular manifestations, in whom PAN was diagnosed through combined analysis of symptoms, laboratory tests, and angiographic findings. Early angioplasty and treatment with glucocorticoids and azathioprine resulted in a favorable response. Case 2 was a woman with TA who had extensive involvement of the aorta and its branches with irreversible sequelae, including aortic valve replacement. Diagnostic delay led to progression. Glucocorticoids and adalimumab achieved clinical stabilization without reversing established structural damage. CONCLUSIONS The presented cases reinforce the importance of early identification and appropriate differentiation of systemic vasculitides to prevent irreversible vascular lesions. This study compares a case of PAN diagnosed early, with vascular intervention preventing ischemic complications, and a case of TA diagnosed late, with permanent structural damage despite treatment. Early use of vascular imaging combined with prompt immunosuppressive therapy and multidisciplinary management contributes to a favorable prognosis, highlighting the need for greater clinical awareness and careful diagnostic strategies in rare vasculitides.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.